Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-18-004796

Director acquired 12,345 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

TARNOW MICHAEL M · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-21 Exercise or conversion : show line 1 in the form +5,144 $3.70 $19,033 60,311 D
2018-06-21 Exercise or conversion : show line 2 in the form +2,057 $3.66 $7,529 62,368 D
2018-06-21 Exercise or conversion : show line 3 in the form +5,144 $3.07 $15,792 67,512 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-06-21 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −5,144 0 D
2018-06-21 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −2,057 0 D
2018-06-21 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,144 0 D
Loading xslF345X03/formfour.xml…